31 – 40 of 2337
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2025
-
Mark
Aggregation potency and proinflammatory effects of SARS-CoV-2 proteins
- Contribution to journal › Article
-
Mark
ATOR-4066, a bispecific antibody targeting CD40 and CEACAM5, induces strong myeloid and T cell-dependent tumor immunity and synergizes with PD-1 blockade
- Contribution to journal › Article
-
Mark
CD40 agonist mitazalimab with mFOLFIRINOX in untreated metastatic pancreatic cancer : Biomarkers associated with outcomes from OPTIMIZE-1
- Contribution to journal › Article
-
Mark
The conserved N-terminal histidine in an engineered peptide mediates sepsis treatment efficacy via dual binding to CD14 and LPS
(2025) In Molecular Therapy
- Contribution to journal › Article
-
Mark
Coordinated humoral and cellular immune responses to COVID-19 vaccination in non-small cell lung cancer patients treated with immune checkpoint inhibitors
- Contribution to journal › Article
-
Mark
Response to Comment on : Multimorbidity, comorbidity, frailty, and venous thromboembolism
- Contribution to journal › Letter
-
Mark
The melanoma MEGA-study : Integrating proteogenomics, digital pathology, and AI-analytics for precision oncology
- Contribution to journal › Article
-
Mark
Antigenic peptide delivery to antigen-presenting cells using a CD40-coiled coil affinity-based platform
- Contribution to journal › Article
-
Mark
Editorial : Allergen-specific antibodies: from basic science to clinical application
- Contribution to journal › Debate/Note/Editorial
-
Mark
Receptor Binding for the Entry Mechanisms of SARS-CoV-2 : Insights from the Original Strain and Emerging Variants
- Contribution to journal › Scientific review
